Myelodysplastic syndromes: clinical practice guidelines in oncology.

Published

Journal Article

The myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic disorders characterized by cytopenias, dysplasia in one or more myeloid lineages, and the potential for development of acute myeloid leukemia. These disorders primarily affect older adults. The NCCN Clinical Practice Guidelines in Oncology for MDS provide recommendations on the diagnostic evaluation and classification of MDS, risk evaluation according to established prognostic assessment tools (including the new revised International Prognostic Scoring System), treatment options according to risk categories, and management of related anemia.

Full Text

Duke Authors

Cited Authors

  • Greenberg, PL; Attar, E; Bennett, JM; Bloomfield, CD; Borate, U; De Castro, CM; Deeg, HJ; Frankfurt, O; Gaensler, K; Garcia-Manero, G; Gore, SD; Head, D; Komrokji, R; Maness, LJ; Millenson, M; O'Donnell, MR; Shami, PJ; Stein, BL; Stone, RM; Thompson, JE; Westervelt, P; Wheeler, B; Shead, DA; Naganuma, M

Published Date

  • July 2013

Published In

Volume / Issue

  • 11 / 7

Start / End Page

  • 838 - 874

PubMed ID

  • 23847220

Pubmed Central ID

  • 23847220

Electronic International Standard Serial Number (EISSN)

  • 1540-1413

Digital Object Identifier (DOI)

  • 10.6004/jnccn.2013.0104

Language

  • eng

Conference Location

  • United States